Literature DB >> 32580808

Substance-related exogenous psychosis: a postmodern syndrome.

Giovanni Martinotti1, Luisa De Risio2, Chiara Vannini1, Fabrizio Schifano3, Mauro Pettorruso1, Massimo Di Giannantonio1.   

Abstract

There is growing recognition that substance use is associated with the emergence of psychosis.Elements of post-modernity dominate contemporary social contexts and operate as existential background factors that contribute to the emergence of substance-related psychotic phenomena, particularly use of potent and highly rewarding novel psychoactive substances (NPS). About 25% of first-episode psychoses are substance-induced (SIP). DSM-5 SIP diagnosis is based on the assumption that symptoms are transient and disappear after sustained abstinence. This narrowed definition does not consider the issue of persistent SIP. There is a clear need for a new diagnostic framework that provides reliable, unambiguous clinical criteria to differentiate between comorbid conditions (i.e., schizophrenia patients with a substance use disorder) and substance-related psychoses. In the present contribution, we aim to outline a novel and separate clinical entity: substancerelated exogenous psychosis (SREP). Within this diagnostic category, we refer to both transientand persistent psychoses associated with substance use. SREP is conceived as a distinct psychoticdisorder with psychopathological specificities that clearly differentiate it from schizophrenia. We address differences in terms of clinical presentation, epidemiology, etiological models and treatment response. SREP is characterized by altered states of consciousness, persecutory delusions, visual and cenesthetic hallucinations, impulsivity and psychomotor agitation, affectiveand negative symptoms, a pervasive feeling of unreality and intact insight. Delusions are typically secondary to abnormal perception resulting from a characteristic "sensorialization" of the world. Longitudinal studies are warranted to substantiate our hypothesis of a novel diagnostic categoryand support the clinical validity of SREP. This may have important implications in terms of early differential diagnosis and staging (i.e., between comorbid conditions, persistent and transientsubstance-related psychotic states) as well as choice of treatment interventions.

Entities:  

Keywords:  Psychosis; mental health; novel psychoactive substances; psychopathology; substance abuse

Mesh:

Year:  2020        PMID: 32580808     DOI: 10.1017/S1092852920001479

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  20 in total

1.  Psychosocial and health problems associated with alcohol use disorder and cannabis use disorder in U.S. adults.

Authors:  Sarah Gutkind; David S Fink; Dvora Shmulewitz; Malka Stohl; Deborah Hasin
Journal:  Drug Alcohol Depend       Date:  2021-10-28       Impact factor: 4.492

2.  Meta-Analysis of Structural and Functional Brain Abnormalities in Cocaine Addiction.

Authors:  Jinghan Dang; Qiuying Tao; Xiaoyu Niu; Mengzhe Zhang; Xinyu Gao; Zhengui Yang; Miaomiao Yu; Weijian Wang; Shaoqiang Han; Jingliang Cheng; Yong Zhang
Journal:  Front Psychiatry       Date:  2022-06-24       Impact factor: 5.435

3.  Club Drugs: Psychotropic Effects and Psychopathological Characteristics of a Sample of Inpatients.

Authors:  Giovanni Martinotti; Attilio Negri; Stefania Schiavone; Chiara Montemitro; Chiara Vannini; Gaia Baroni; Mauro Pettorruso; Fabio De Giorgio; Raffaele Giorgetti; Valeria Verrastro; Luigia Trabace; Andres Garcia; Ivan Castro; Juan Iglesias Lopez; Cristina Merino Del Villar; Fabrizio Schifano; Massimo di Giannantonio
Journal:  Front Psychiatry       Date:  2020-08-31       Impact factor: 4.157

4.  Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others-A Perspective of German Addiction Medicine Experts.

Authors:  Udo Bonnet; Michael Specka; Michael Soyka; Thomas Alberti; Stefan Bender; Torsten Grigoleit; Leopold Hermle; Jörg Hilger; Thomas Hillemacher; Thomas Kuhlmann; Jens Kuhn; Christian Luckhaus; Christel Lüdecke; Jens Reimer; Udo Schneider; Welf Schroeder; Markus Stuppe; Gerhard A Wiesbeck; Norbert Wodarz; Heath McAnally; Norbert Scherbaum
Journal:  Front Psychiatry       Date:  2020-10-26       Impact factor: 4.157

5.  Toxic Nightlife Relationships, Substance Abuse, and Mental Health: Is There a Link? A Qualitative Case Study of Two Patients.

Authors:  Sandra Racionero-Plaza; Juan Antonio Piñero León; Manuel Morales Iglesias; Leire Ugalde
Journal:  Front Psychiatry       Date:  2021-01-21       Impact factor: 4.157

6.  Prescription Drug Misuse in "Clubbers" and Disco Goers in Ibiza.

Authors:  Massimo di Giannantonio; Attilio Negri; Stefania Schiavone; Chiara Vannini; Mauro Pettorruso; Fabio De-Giorgio; Valeria Verrastro; Luigia Trabace; Mariangela Corbo; Rossella Gottardo; Cristian Camuto; Monica Mazzarino; Andrea Barra; Domenico De Berardis; Juan Iglesias Lopez; Cristina Merino Del Villar; Fabrizio Schifano; Giovanni Martinotti
Journal:  Front Psychiatry       Date:  2020-12-15       Impact factor: 4.157

7.  Suicidality Presented to a Child and Adolescent Psychiatry Emergency Service: Increasing Rate and Changing Characteristics.

Authors:  Stephanie Kandsperger; Irina Jarvers; Daniel Schleicher; Angelika Ecker; Michael Wirth; Romuald Brunner
Journal:  Front Psychiatry       Date:  2021-07-15       Impact factor: 4.157

8.  Application of Novel Psychoactive Substances: Chemsex and HIV/AIDS Policies Among Men Who Have Sex With Men in Hong Kong.

Authors:  Alex Siu Wing Chan; Patrick Ming Kuen Tang
Journal:  Front Psychiatry       Date:  2021-07-14       Impact factor: 4.157

9.  Club Drugs and Psychiatric Sequelae: An Issue of Vulnerability and Previous Psychiatric History.

Authors:  Giovanni Martinotti; Cristina Merino Del Villar; Andrés Garcia Cordoba; Lluís Andrés Tubau; Ivan Castro Sánchez; Francesco Di Carlo; Stefania Chiappini; Mauro Pettorruso; Fabrizio Schifano; Massimo Di Giannantonio
Journal:  Int J Environ Res Public Health       Date:  2021-06-29       Impact factor: 3.390

Review 10.  Psychosis in Women: Time for Personalized Treatment.

Authors:  Marianna Mazza; Emanuele Caroppo; Domenico De Berardis; Giuseppe Marano; Carla Avallone; Georgios D Kotzalidis; Delfina Janiri; Lorenzo Moccia; Alessio Simonetti; Eliana Conte; Giovanni Martinotti; Luigi Janiri; Gabriele Sani
Journal:  J Pers Med       Date:  2021-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.